Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATH-wSP vaccine in Kenyan adults and toddlers
NCT02543892Phase 2Completed
- Sponsor
- PATH
- Start
- Aug 2016
- Primary completion
- Jan 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of wSp vaccine in pneumonia, sponsored by PATH. Started Aug 2016; status: completed.
02
Drugs
wSp vaccine
03
Conditions
pneumonia
Beyond the preview
Go deeper on NCT02543892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02543892.